Acurx Pharma receives positive regulatory guidance from EMA for ibezapolstat phase 3 programme for C. difficile infection: Staten Island, New York Tuesday, January 7, 2025, 18:00 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback